Glenmark Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated October 29, 2009, titled "Glenmarks consolidated revenue increases by 5% to Rs. 5903.26 Mn for Q2-FY10. Consolidated Net Profit at Rs. 808.85 million". The Company has further submitted to the Exchange a copy of the Management Discussion and Analysis for the second quarter of the Financial Year 2009-10 ended September 30, 2009. The copies of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).
| NIFTY 
